Close Menu

NEW YORK – Gradientech said on Friday it has been awarded SEK6.3 million ($634,000) from the Bio-X Accelerate program to help commercialize its QuickMIC diagnostic system.

"The funding received from the Bio-X Accelerate program will definitely help us towards a faster market introduction of the QuickMIC system, both by advancing the production transfer process of our antibiotic panels, and by securing our clinical performance evaluation," Gradientech Product Manager Teresa Fernandez Zafra said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.